Report cover image

Global Non-Hormonal Contraception Market

Published Jun 20, 2025
Length 255 Pages
SKU # SKTC20314754

Description

Global Non-Hormonal Contraception Market size was valued at USD 30.67 billion in 2023 and is poised to grow from USD 32.66 billion in 2024 to USD 54.06 billion by 2032, growing at a CAGR of 6.5% during the forecast period (2024-2032).

The global landscape of non-hormonal contraception encompasses various methods aimed at preventing fertilization or implantation without the use of hormones. Key types include barrier methods, which consist of male and female condoms, diaphragms, and cervical caps, creating a physical barrier to sperm. These methods are widely accessible, user-friendly, and carry minimal side effects, although they demand consistent application and do not offer STI protection. Additionally, fertility awareness methods involve monitoring a woman’s menstrual cycle to avoid intercourse during fertile periods, though they may be less effective for those with irregular cycles. Lastly, intrauterine devices (IUDs), available in copper forms, provide a long-lasting, highly effective option that doesn't require daily management, though they may pose some risks and discomfort during insertion.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Non-Hormonal Contraception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Hormonal Contraception Market Segments Analysis

Global Non-Hormonal Contraception Market is segmented by Method, Gender, Accessibility, Age Group, Distribution Channel, End User and region. Based on Method, the market is segmented into Barrier Method, Spermicidal, Sterilization and Other Methods. Based on Gender, the market is segmented into Male and Female. Based on Accessibility, the market is segmented into Over-the-Counter (OTC) and Prescription-Based. Based on Age Group, the market is segmented into 13-19 Years, 20-29 Years, 30-39 Years and 40+ Years. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Online Platforms, Government & NGO Distribution Channels and Others. Based on End User, the market is segmented into Hospital, Clinics, Ambulatory Surgical Centers and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market is significantly driven by rising awareness surrounding contraceptive options. As more individuals embrace family planning and search for effective and safe methods, the appeal of non-hormonal alternatives has surged. Increased access to educational materials and counseling services has empowered consumers with knowledge about the diverse contraceptive choices available, leading to heightened demand for non-hormonal solutions. This shift reflects a preference for products that prioritize safety and efficacy, tailored to personal needs. In response, manufacturers are focused on innovation, creating new non-hormonal contraceptive products to cater to this evolving market landscape and consumer desire.

Restraints in the Global Non-Hormonal Contraception Market

The global non-hormonal contraception market is constrained by limited availability and awareness, particularly in developing regions. These areas often suffer from inadequate infrastructure and resources, which restrict access to non-hormonal contraceptive options. Furthermore, cultural and religious beliefs can significantly influence the perception and acceptance of contraceptives, leading to reduced usage and availability. This situation not only contributes to unintended pregnancies but also elevates the rates of sexually transmitted infections, ultimately impeding the growth potential of the non-hormonal contraception market. Addressing these challenges is crucial for expanding access and promoting awareness in these underserved communities.

Market Trends of the Global Non-Hormonal Contraception Market

A prominent trend in the global non-hormonal contraception market is the rising consumer preference for natural and organic contraceptive options. Heightened awareness of the potential side effects linked to hormonal contraceptives is steering individuals toward alternatives that are devoid of synthetic hormones and chemicals. This shift is manifesting in an increased interest in products such as condoms, menstrual cups, and natural family planning methods, which are viewed as safer and more environmentally sustainable. Additionally, the growing emphasis on sustainability and eco-friendliness is further catalyzing this trend, as consumers seek out contraceptive solutions that align with their values of health and environmental responsibility.

Table of Contents

255 Pages
1. Introduction
1.1. Objectives of the Study
1.2. Market Definition & Scope
2. Research Methodology
2.1. Research Process
2.2. Secondary & Primary Data Methods
2.3. Market Size Estimation Methods
2.4. Market Assumptions & Limitations
3. Executive Summary
3.1. Global Market Outlook
3.2. Key Market Highlights
3.3. Segmental Overview
3.4. Competition Overview
4. Market Dynamics & Outlook
4.1. Macro-Economic Indicators
4.2. Drivers & Opportunities
4.3. Restraints & Challenges
4.4. Supply Side Trends
4.5. Demand Side Trends
4.6. Porters Analysis & Impact
4.6.1. Competitive Rivalry
4.6.2. Threat of Substitute
4.6.3. Bargaining Power of Buyers
4.6.4. Threat of New Entrants
4.6.5. Bargaining Power of Suppliers
5. Key Market Insights
5.1. Key Success Factors
5.2. Market Impact Factor
5.3. Top Investment Pockets
5.4. Market Ecosystem
5.5. Market Attractiveness Index
5.6. Clinical Trial Analysis
5.7. Patent Analysis
5.8. Case Study Analysis
5.9. PESTEL Analysis
5.10. Regulatory Analysis
5.11. Pipeline Analysis
5.12. Technology Analysis
5.13. Fertility Awareness Method Users
6. Global Non-Hormonal Contraception Market Size by Method (Value/Volume) (2019-2032)
6.1. Market Overview
6.2. Barrier Method
6.2.1. Condoms
6.2.1.1. Male
6.2.1.2. Female
6.2.2. Diaphragms
6.2.3. Cervical Caps
6.2.4. Non-Hormonal IUDs
6.2.5. Contraceptive Sponges
6.2.6. Other Devices
6.3. Spermicidal
6.4. Sterilization
6.4.1. Male Sterilization (Vasectomy)
6.4.1.1. No-scalpel Vasectomy
6.4.1.2. Conventional Vasectomy
6.4.1.3. Minimally Invasive Vasectomy
6.4.2. Female Sterilization (Tubal Ligation)
6.4.2.1. Laparoscopic Tubal Ligation
6.4.2.2. Hysteroscopic Tubal Ligation
6.4.2.3. Mini-Laparotomy
6.4.2.4. Other Tubal Procedures
6.5. Other Methods
7. Global Non-Hormonal Contraception Market Size by Gender (2019-2032)
7.1. Market Overview
7.2. Male
7.3. Female
8. Global Non-Hormonal Contraception Market Size by Accessibility (2019-2032)
8.1. Market Overview
8.2. Over-the-Counter (OTC)
8.3. Prescription-Based
9. Global Non-Hormonal Contraception Market Size by Age Group (2019-2032)
9.1. Market Overview
9.2. 13-19 Years
9.3. 20-29 Years
9.4. 30-39 Years
9.5. 40+ Years
10. Global Non-Hormonal Contraception Market Size by Distribution Channel (2019-2032)
10.1. Market Overview
10.2. Hospital Pharmacies
10.3. Retail Pharmacies
10.4. Online Platforms
10.5. Government & NGO Distribution Channels
10.6. Others
11. Global Non-Hormonal Contraception Market Size by End-User (2019-2032)
11.1. Market Overview
11.2. Hospital
11.3. Clinics
11.4. Ambulatory Surgical Centers
11.5. Others
12. Global Non-Hormonal Contraception Market Size (2019-2032)
12.1. North America (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
12.1.1. US
12.1.2. Canada
12.2. Europe (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
12.2.1. UK
12.2.2. Germany
12.2.3. Spain
12.2.4. France
12.2.5. Italy
12.2.6. Rest of Europe
12.3. Asia-Pacific (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
12.3.1. China
12.3.2. India
12.3.3. Japan
12.3.4. South Korea
12.3.5. Rest of Asia Pacific
12.4. Latin America (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Middle East & Africa (By Method, By Gender, By Accessibility, By Age Group, By Distribution Channel, & By End-User)
12.5.1. GCC Countries
12.5.2. South Africa
12.5.3. Rest of Middle East & Africa
13. Competitive Dashboard
13.1. Top 5 Player Comparison
13.2. Market Positioning of Key Players, 2024
13.3. Strategies Adopted by Key Market Players
13.4. Recent Developments in the Market
13.5. Company Market Share Analysis, 2024
14. Key Company Profiles
14.1. Evofem Biosciences
14.1.1. Company Overview
14.1.2. Product Portfolio Overview
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. The following companies are listed for indicative purposes only. Similar information will be provided for each, with detailed financial data available exclusively for publicly listed companies.
14.3. Daré Bioscience
14.4. CooperSurgical (Cooper Co.)
14.5. Reckitt Benckiser
14.6. Trojan
14.7. Mayer Laboratories Inc.
14.8. LifeStyles Healthcare
14.9. Kessel Medintim GmbH
14.10. Contraline, Inc.
14.11. YourChoice Therapeutics
14.12. Contrel Europe
14.13. NEXT Life Sciences
14.14. Femasys Inc.
14.15. Apothecus Pharmaceutical
14.16. Sebela Pharmaceuticals (Sebela Women’s Health)
14.17. FemCap Inc.
14.18. Mona Lisa N.V.
14.19. Okamoto Industries, Inc.
14.20. Fuji Latex Co., Ltd.
14.21. Veru Inc.
15. Conclusion & Analyst Recommendations

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.